SOURCE: VitalCare Diabetes Treatment Centers, Inc.

May 06, 2008 07:26 ET

VitalCare Adds Two New Treatment Centers in Indiana

LOI Outlines Two Additional Locations for iCAT Therapy Centers for Diabetics

CARSON CITY, NV--(Marketwire - May 6, 2008) - VitalCare Diabetes Treatment Centers, Inc. (PINKSHEETS: VDTI), a Nevada corporation, today announced they have two additional locations now signed under a Letter Of Intent in the state of Indiana. The centers will be administering the FDA approved iCAT Treatment for diabetes related wound care for Type 1 and Type 2 diabetes patients. This is in addition to a previously announced LOI for the first center to be opened in Indiana by VitalCare.

Jimmy McDougald, CEO of VitalCare, stated, "We are excited about our continued expansion in the Midwest and our iCAT Therapy being available to diabetics in this region."

About VitalCare Diabetes Treatment Centers, Inc.

VitalCare Diabetes Treatment Centers, Inc. is a company specializing in providing Administrative, Marketing, Business Development, Strategic Planning, Clinical Oversight and Clinical Management Services to the Diabetes Healthcare Sector, with an emphasis in bringing "Cutting Edge" medical devices and healthcare services direct to consumers, focusing on an emerging FDA approved, US and European Patented technology and treatment intervention for treating Type 1 and Type 2 Diabetes known as "Intracellular Activation Therapy (iCAT)."

Safe Harbor Statement: Forward-looking statements in this release with respect to VitalCare Diabetes Treatment Centers, Inc.'s business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond VitalCare Diabetes Treatment Centers, Inc.'s control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in VitalCare's filings with the Securities and Exchange Commission.

Contact Information

  • For Further Information Contact:

    VitalCare Diabetes Treatment Centers, Inc.
    Jimmy McDougald
    Investor Relations:
    Office: 1.909.981.9192
    Fax: 1.909.931.1780
    Email: info@vitalcaretechnology.com